A new report from the National Cancer Institute shows a major disparity in the rates of stomach cancer in people of different ...

Leap Therapeutics is discontinuing the development of its anti-DKK1 antibody sirexatamab in gastric cancer after the drug ...

Among those with advanced gastric cancer, oral Liporaxel showed superior overall survival outcomes versus IV Liporaxel as a ...

Former Manchester United and Wales midfielder Mickey Thomas was diagnosed with stomach cancer at the age of 64, with his ...

Shares of Leap Therapeutics (NASDAQ:LPTX) tumbled 64% in pre-open trading Tuesday as the company announced that its ...

Gastric cancer, also known as stomach cancer, is a type of cancer that starts in the stomach lining. Detecting the disease early can improve outcomes, but current methods are often invasive. A new ...

Oral paclitaxel matched IV in progression-free survival but outperformed it in overall survival for second-line advanced gastric cancer.

Marcelo Garcia faces Masakazu Imanari at ONE 170 this Friday, January 24, inside Bangkok, Thailand’s Impact Arena.

Leap Therapeutics, Inc.'s DKN-01 trial results show mixed outcomes in cancer treatment, prompting potential future funding ...

A beloved Cornwall woman is desperately raising funds to carry on lifesaving treatment abroad. Jodi Shepherd, who has been ...

Discover new treatments currently being developed for pancreatic cancer, which has historically been extremely difficult to ...

The phase 3 CheckMate 649 trial showed that nivolumab plus chemotherapy significantly improved long-term overall survival in ...